Patents by Inventor Charles McWherter

Charles McWherter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of intrahepatic cholestatic diseases
    Patent number: 11596614
    Abstract: Treatment of intrahepatic cholestatic diseases by therapy with seladelpar or a salt thereof.
    Type: Grant
    Filed: April 3, 2021
    Date of Patent: March 7, 2023
    Assignee: CymaBay Therapeutics, Inc.
    Inventors: Pol Boudes, Charles A. McWherter
  • Treatment of intrahepatic cholestatic diseases
    Patent number: 11406611
    Abstract: Treatment of intrahepatic cholestatic diseases by therapy with MBX-8025 or an MBX-8025 salt.
    Type: Grant
    Filed: October 3, 2020
    Date of Patent: August 9, 2022
    Assignee: CymaBay Therapeutics, Inc.
    Inventors: Pol Boudes, Charles A. McWherter
  • Treatment of cholangiopathies
    Publication number: 20220241228
    Abstract: Seladelpar and its salts are useful in the treatment of cholangiopathies in subjects who are intolerant of, or have an inadequate response to, obeticholic acid and/or fibrates.
    Type: Application
    Filed: January 29, 2022
    Publication date: August 4, 2022
    Applicant: CymaBay Therapeutics, Inc.
    Inventors: Yun-Jung Choi, Charles A. McWherter, Alexandra S. Steinberg, Ke Yang
  • Treatment of intrahepatic cholestatic diseases
    Patent number: 11224580
    Abstract: Treatment of intrahepatic cholestatic diseases by therapy with seladelpar or a salt thereof.
    Type: Grant
    Filed: September 18, 2020
    Date of Patent: January 18, 2022
    Assignee: CymaBay Therapeutics, Inc.
    Inventors: Pol Boudes, Charles A. McWherter
  • Treatment of NAFLD and NASH
    Patent number: 11179359
    Abstract: Treatment of NAFLD and NASH by therapy with MBX-8025 or an MBX-8025 salt.
    Type: Grant
    Filed: June 19, 2020
    Date of Patent: November 23, 2021
    Assignee: CymaBay Therapeutics, Inc.
    Inventors: Brian Roberts, Xueyan Wang, Yun-Jung Choi, David Karpf, Robert Martin, Charles McWherter
  • CB-0406 choline salt
    Publication number: 20210355066
    Abstract: CB-0406 choline salt, especially in crystalline form and as an ansolvate, methods of preparing it, compositions containing it, and its pharmaceutical uses.
    Type: Application
    Filed: May 12, 2021
    Publication date: November 18, 2021
    Applicants: CymaBay Therapeutics, Inc., DiaTex, Inc.
    Inventors: Stephan X.M. Boerrigter, Charles A. McWherter, Robert L. Martin, Jennifer L. Nelson, Jiangao Song
  • CB-0406 tromethamine salt
    Publication number: 20210355065
    Abstract: CB-0406 tromethamine salt, especially in crystalline form and as an ansolvate, methods of preparing it, compositions containing it, and its pharmaceutical uses.
    Type: Application
    Filed: May 12, 2021
    Publication date: November 18, 2021
    Applicants: CymaBay Therapeutics, Inc., DiaTex, Inc.
    Inventors: Stephan X.M. Boerrigter, Charles A. McWherter, Robert L. Martin, Jennifer L. Nelson, Jiangao Song
  • Treatment of cholestatic pruritus
    Publication number: 20210283078
    Abstract: Treatment of cholestatic pruritus by therapy with seladelpar or a salt thereof.
    Type: Application
    Filed: December 21, 2020
    Publication date: September 16, 2021
    Applicant: CymaBay Therapeutics, Inc.
    Inventors: Pol Boudes, Charles A. McWherter, Alexandra S. Steinberg
  • Treatment of intrahepatic cholestatic diseases
    Publication number: 20210220305
    Abstract: Treatment of intrahepatic cholestatic diseases by therapy with seladelpar or a salt thereof.
    Type: Application
    Filed: April 3, 2021
    Publication date: July 22, 2021
    Applicant: CymaBay Therapeutics, Inc.
    Inventors: Pol Boudes, Charles A. McWherter
  • Treatment of intrahepatic cholestatic diseases
    Patent number: 11000494
    Abstract: Treatment of intrahepatic cholestatic diseases by therapy with seladelpar or a salt thereof.
    Type: Grant
    Filed: September 18, 2020
    Date of Patent: May 11, 2021
    Assignee: CymaBay Therapeutics, Inc.
    Inventors: Pol Boudes, Charles A. McWherter
  • Treatment of NAFLD and NASH
    Publication number: 20210038546
    Abstract: Treatment of NAFLD and NASH by therapy with MBX-8025 or an MBX-8025 salt.
    Type: Application
    Filed: June 19, 2020
    Publication date: February 11, 2021
    Applicant: CymaBay Therapeutics, Inc.
    Inventors: Brian Roberts, Xueyan Wang, Yun-Jung Choi, David Karpf, Robert Martin, Charles McWherter
  • Treatment of intrahepatic cholestatic diseases
    Publication number: 20210023031
    Abstract: Treatment of intrahepatic cholestatic diseases by therapy with MBX-8025 or an MBX-8025 salt.
    Type: Application
    Filed: October 3, 2020
    Publication date: January 28, 2021
    Applicant: CymaBay Therapeutics, Inc.
    Inventors: Pol Boudes, Charles A. McWherter
  • Treatment of intrahepatic cholestatic diseases
    Publication number: 20210000773
    Abstract: Treatment of intrahepatic cholestatic diseases by therapy with seladelpar or a salt thereof.
    Type: Application
    Filed: September 18, 2020
    Publication date: January 7, 2021
    Applicant: CymaBay Therapeutics, Inc.
    Inventors: Pol Boudes, Charles A. McWherter
  • Treatment of intrahepatic cholestatic diseases
    Publication number: 20210000774
    Abstract: Treatment of intrahepatic cholestatic diseases by therapy with seladelpar or a salt thereof.
    Type: Application
    Filed: September 18, 2020
    Publication date: January 7, 2021
    Applicant: CymaBay Therapeutics, Inc.
    Inventors: Pol Boudes, Charles A. McWherter
  • Treatment of intrahepatic cholestatic diseases
    Patent number: 10828273
    Abstract: Treatment of intrahepatic cholestatic diseases by therapy with MBX-8025 or an MBX-8025 salt.
    Type: Grant
    Filed: December 17, 2018
    Date of Patent: November 10, 2020
    Assignee: CymaBay Therapeutics, Inc.
    Inventors: Pol Boudes, Charles A. McWherter
  • Treatment of intrahepatic cholestatic diseases
    Patent number: 10813895
    Abstract: Treatment of intrahepatic cholestatic diseases by therapy with seladelpar or a salt thereof.
    Type: Grant
    Filed: October 9, 2019
    Date of Patent: October 27, 2020
    Assignee: CymaBay Therapeutics, Inc.
    Inventors: Pol Boudes, Charles A. McWherter
  • Treatment of intrahepatic cholestatic diseases
    Patent number: 10813896
    Abstract: Treatment of intrahepatic cholestatic diseases by therapy with seladelpar or a salt thereof.
    Type: Grant
    Filed: November 6, 2019
    Date of Patent: October 27, 2020
    Assignee: CymaBay Therapeutics, Inc.
    Inventors: Pol Boudes, Charles A. McWherter
  • Treatment of NAFLD and NASH
    Patent number: 10722483
    Abstract: Treatment of NAFLD and NASH by therapy with MBX-8025 or an MBX-8025 salt.
    Type: Grant
    Filed: May 23, 2019
    Date of Patent: July 28, 2020
    Assignee: CymaBay Therapeutics, Inc.
    Inventors: Brian Roberts, Xueyan Wang, Yun-Jung Choi, David Karpf, Robert Martin, Charles McWherter
  • Treatment of obesity and its complications
    Publication number: 20200155487
    Abstract: Combination treatment of obesity and its complications with seladelpar or a salt thereof and a glucagon-like peptide-1 (GLP-1) receptor agonist.
    Type: Application
    Filed: November 13, 2019
    Publication date: May 21, 2020
    Applicant: CymaBay Therapeutics, Inc.
    Inventors: Yun-Jung Choi, Charles A McWherter
  • Combination treatment of NAFLD and NASH
    Publication number: 20200155650
    Abstract: Combination treatment of NAFLD, including NASH, with seladelpar or a salt thereof and a glucagon-like peptide-1 (GLP-1) receptor agonist.
    Type: Application
    Filed: November 13, 2019
    Publication date: May 21, 2020
    Applicant: CymaBay Therapeutics, Inc.
    Inventors: Yun-Jung Choi, Charles A. McWherter